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Background: The emergence and wide distribution of the transferable gene for linezolid resistance, cfr, in staphylococci
of human and animal origins is of great concern as it poses a serious threat to the public health. In the present study,
we investigated the emergence and presence of the multiresistance gene, cfr, in retail meat sourced from supermarkets
and free markets of Guangzhou, China.
Results: A total of 118 pork and chicken samples, collected from Guangzhou markets, were screened by PCR for cfr.
Twenty-two Staphylococcus isolates obtained from 12 pork and 10 chicken samples harbored cfr. The 22 cfr-positive
staphylococci isolates, including Staphylococcus equorum (n = 8), Staphylococcus simulans (n = 7), Staphylococcus cohnii
(n = 4), and Staphylococcus sciuri (n = 3), exhibited 17 major SmaI pulsed-field gel electrophoresis (PFGE) patterns. In 14
isolates, cfr was located on the plasmids. Sequence analysis revealed that the genetic structures (including ΔtnpA of
Tn558, IS21-558, ΔtnpB, and tnpC of Tn558, orf138, fexA) of cfr in plasmid pHNTLD18 of a S. sciuri strain and in the
plasmid pHNLKJC2 (including rep, Δpre/mob, cfr, pre/mob and partial ermC) of a S. equorum strain were identical
or similar to the corresponding regions of some plasmids in staphylococcal species of animal and human origins.
Conclusions: To the best of our knowledge, this is the first study to report the presence of the multiresistance gene,
cfr, in animal meat. A high occurrence of cfr was observed in the tested retail meat samples. Thus, it is important to
monitor the presence of cfr in animal foods in China.
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Linezolid is considered to as the last treatment option
for infections caused by methicillin-resistant Staphylococ-
cus aureus (MRSA), vancomycin-resistant Enterococci and
penicillin-resistant Streptococcus [1]. Mutations in the drug
target site (23S rRNA or ribosomal proteins L3 and L4) are
the most common mechanisms of linezolid resistance. Due
to the low frequency of target mutation, the frequency
of linezolid resistance is also relatively low [2]. However,
emergence of the transferable linezolid resistance gene,
cfr, in clinical isolates poses a challenge in linezolid
treatment. cfr gene encodes an RNA methyltransferase,
which modifies the adenine residue at position 2503 of
the 23S rRNA gene and thereby confers resistance to
phenicols, lincosamides, oxazolidinones, pleuromutilins,* Correspondence: jhliu@scau.edu.cn
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unless otherwise stated.and streptogramin A antibiotics (the PhLOPSA phenotype)
as well as decreases susceptibility to the 16-membered
macrolides spiramycin and josamysin [3-5].
Since its first detection from a bovine Staphylococcus
sciuri isolate in 1997 [6], cfr has been globally transmitted
among different bacteria, such as Staphylococcus spp.,
Enterococcus spp., Macrococcus spp., Jeotgalicoccus spp.,
Streptococcus suis, Escherichia coli, Bacillus spp., Proteus
vulgaris [7,8]. This gene is widely distributed in the iso-
lates of both human and animal origin, especially in China
[8]. A recent study has described this gene in farm envi-
ronments [9]. However, there has been no study on the
distribution of cfr in retail meat. In the present study,
we investigated the presence and the genetic back-
ground of this multiresistance gene in retail meat sam-
ples sourced from supermarkets and free markets of
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Identification of cfr-positive Staphylococcus isolates
Of the 118 retail meat samples tested, a total of 22
cfr-positive Staphylococcus isolates were detected in 12
pork samples and 10 chicken samples. The 22 cfr-positive
staphylococcal isolates included Staphylococcus equorum
(n = 8), Staphylococcus simulans (n = 7), Staphylococ-
cus cohnii (n = 4), and Staphylococcus sciuri (n = 3). In
addition, one cfr-positive Macrococcus caseolyticus isolate
was obtained from a chicken sample. In total, 15.8% and
26.2% pork and chicken samples carried cfr-positive iso-
lates, respectively.Clonal analysis of cfr-positive staphylococci and location
of cfr
Pulsed-field gel electrophoresis (PFGE) of 22 cfr-positive
staphylococci revealed 17 major SmaI PFGE patterns
(Table 1). Eight S. equorum isolates showed five different
PFGE patterns, with two chicken strains from the same
market presenting indistinguishable patterns. Six distinct
PFGE patterns were identified for the seven S. simulans
isolates, with only two pork isolates from different
markets presenting similar PFGE patterns. For the four
S. cohnii isolates, three PFGE patterns were identified,
with two pork isolates from the same market presenting
identical patterns. Each of the three S. sciuri isolates ex-
hibited distinct PFGE patterns. In summary, most of the
cfr-positive staphylococcal isolates were genetically dis-
tinct, but a clonal transfer of cfr-positive staphylococcal
isolates had occurred either in the same or among differ-
ent markets.
Results of Southern blotting indicated that 14 isolates
harbored cfr in their plasmid DNA (Table 1). The remaining
eight isolates appeared to carry cfr in their genomic DNA;
however, this assumption needs to be further confirmed
by S1-PFGE. Only one cfr-carrying plasmid (designated as
pHNLKJC2) that originated from a chicken isolate,
TLKJC2, was transformed into Staphylococcus aureus
RN4220. The transformant was confirmed by polymerase
chain reaction (PCR) for cfr; it showed the same PFGE
pattern as that of Staphylococcus aureus RN4220.Antimicrobial susceptibility of cfr-positive Staphylococcus
isolates and the transformants
All of the 22 cfr-positive staphylococcal isolates had elevated
minimum inhibitory concentrations (MICs) against chlor-
amphenicol (16 to > 64 mg/L), florfenicol (32 to >64 mg/L),
clindamycin (≥64 mg/L), tiamulin (64 to > 128 mg/L), val-
nemulin (0.5 to >64 mg/L), and linezolid (2 to 16 mg/L)
(Table 1). In addition, 18, 14, 13, 17, 6, and 17 isolates ex-
hibited resistance to oxacillin, ciprofloxacin, gentamicin,
erythromycin, rifampicin, and tetracycline, respectively. All
isolates were found to be susceptible to vancomycin.Compared with S. aureus RN4220, the transformant
carrying pHNLKJC2 had elevated MICs against chlor-
amphenicol (8-fold), florfenicol (16-fold), clindamycin
(64-fold), tiamulin (32-fold), valnemulin (32-fold), and
linezolid (4-fold) (Table 1), supporting the presence
and the functional activity of cfr. In addition, the trans-
formant carrying pUC18-cfr exhibited 2-fold-elevated
MICs for chloramphenicol and florfenicol as compared
to E. coli DH5α.
Analysis of the genetic environment of cfr in the plasmid
pHNTLD18 and pHNLKJC2
Southern blotting confirmed that, in Staphylococcus
equorum TLD18, cfr was located on a plasmid designed
as pHNTLD18. An approximately 5.7-kb EcoRI fragment
containing cfr was cloned and sequenced. A Tn558 vari-
ant was identified on the plasmid pHNTLD18, in which
parts of the Tn558-associated transposase genes tnpA and
tnpB were replaced by a cfr-carrying segment and the in-
sertion sequence IS21-558 (Figure 1A). Another resistance
gene, fexA, encoding an exporter that mediates the active
efflux of phenicols, was found to be located downstream
of Tn558.
The sequences 1,926-bp upstream and 2,659-bp down-
stream of cfr on the plasmid pHNLKJC2 were obtained
by primer walking. Basic local alignment search tool
(BLAST) analysis of these sequences revealed a 3′-
truncated segment of the gene pre/mob upstream of
cfr. Further upstream, an incomplete rep gene was de-
tected. Analysis of the region downstream of cfr revealed
the presence of a complete pre/mob gene. Immedi-
ately downstream of the pre/mob gene, an incomplete
macrolide-lincosamide-streptogramin B (MLSB) resistance
gene ermC was detected (Figure 1B).
Discussion
Lack of previous studies on the distribution of the multi-
resistance gene cfr among staphylococci in retail meat
led us to screen 118 meat samples for the same. In our
analysis, cfr was detected in 22 samples. The detection
rate was 18.6%, which is higher than the detection rates
of food animal samples in China [10,11]. The low fitness
cost of cfr acquisition observed in staphylococcal isolates
may account for the persistence of this multiresistance
gene in retail meat even in the absence of an antimicrobial
selection pressure [12]. The high detection rate found in
this study suggested that cfr may be widely disseminated
among staphylococci in the meats sold in China, increas-
ing the possibility of this gene entering the food chain.
In this study, S. equorum (n = 8) was the predominant
species among the 22 cfr-carrying isolates obtained from
animal food sources. To the best of our knowledge, this
is the first report of cfr in S. equorum. S. equorum was
originally isolated from the skin of horses and was later







MIC values of antimicrobial
agents (mg/L)c
Other resistance patternsd
CHL FFC CLR TIA VAL LZD
TDP5 S. cohnii Pork 1 C P 16 >64 >64 128 64 2 OXA, CIP, GEN, ERY, TET
TDPJC2 S. cohnii Chicken 1 P ND 32 32 >64 64 0.5 2 OXA, CIP, ERY
TYT5 S. cohnii Pork 3 F P 32 32 64 128 64 2 TET
TYT7 S. cohnii Pork 3 F P 16 >64 >64 64 16 2 OXA, CIP, GEN, ERY
TDP9 S. equorum Pork 1 D P 32 >64 >64 >128 >64 8 OXA, GEN, ERY, TET
TDPJC9 S. equorum Chicken 1 J P 16 64 >64 128 2 4 OXA, GEN, ERY, TET
TLD18 S. equorum Pork 2 L1 P 16 >64 >64 >128 64 8 OXA, GEN, ERY, TET
TLDJC5 S. equorum Chicken 2 L2 P 64 32 >64 >128 16 4 OXA, CIP, GEN, ERY, RIF, TET
TLDJC9 S. equorum Chicken 2 N P 32 64 >64 >128 2 4 OXA, CIP, GEN, ERY, RIF, TET
TLH5 S. equorum Pork 4 L3 ND 16 >64 >64 128 8 4 OXA, CIP, GEN, ERY, TET
TYTJC3 S. equorum Chicken 3 I ND 16 32 >64 >128 4 4 ERY, TET
TYTJC8 S. equorum Chicken 3 I ND 16 32 64 64 16 2 OXA, CIP, GEN, ERY
TDPJC13 S. sciuri Chicken 1 E P 64 64 >64 >128 32 4 OXA, CIP, GEN, TET
TDPJC5 S. sciuri Chicken 1 R ND 32 >64 >64 >128 >64 16 OXA, GEN, ERY, TET
TLKJC2 S. sciuri Chicken 6 Q P 16 >64 >64 >128 16 8 OXA, CIP, GEN, ERY, TET
TDP12 S. simulans Pork 1 A ND >64 64 64 64 16 4 OXA, CIP, GEN, ERY, RIF
TDP24 S. simulans Pork 1 B ND 32 >64 >64 64 2 4 TET
THTJC2 S. simulans Chicken 5 O P 64 32 >64 >128 4 4 OXA, CIP, GEN, ERY, RIF
TLD12 S. simulans Pork 2 K P >64 >64 >64 >128 64 8 OXA, CIP, GEN, ERY, RIF, TET
TLD20 S. simulans Pork 2 M P >64 >64 >64 128 32 4 OXA, CIP, GEN, ERY, RIF, TET
TLD22 S. simulans Pork 2 G2 P 16 >64 >64 128 8 8 CIP, GEN, ERY, TET
TYT6 S. simulans Pork 3 G1 ND 16 >64 >64 >128 64 4 OXA, ERY, TET
Recipient RN4220 S. aureus 4 4 0.25 0.5 0.25 1 ND
RN4220-pHNLKJC2 S. aureus 32 64 16 16 8 4 ND
DH5α E. coli 4 4 - - - - ND
DH5α-pUC18-cfr E. coli 8 8 - - - - ND
ATCC 29213 S. aureus 2 2 0.12 0.5 0.06 1
aPatterns that differed from pattern A by six or more bands were considered to represent different strains. Patterns that differed by fewer than six bands were
considered to represent subtypes within the main group (e.g.,L1, L2).
bP, plasmid; ND, not determined.
cCHL, chloramphenicol; FFC, florfenicol; CLR, clindamycin; TIA, tiamulin; VAL, valnemulin; LZD, linezolid. MIC was not measured because of known intrinsic
resistance or naturally high MICs.
dThe results were interpreted according to Eucast breakpoints (http://www.eucast.org/clinical_breakpoints/). OXA, oxacillin; CIP, ciprofloxacin; GEN, gentamycin;
ERY, erythromycin; RIF, rifamycin; TET, tetracycline. All isolates were susceptible to vancomycin. ND, not determined.
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sausages and cheese samples [13-17]. S. equorum is used
as one of the starter cultures in the preparation of
smear-ripened cheese and cured meats such as sausages
[15,16]. Since S. equorum present in retail meats has rare
chances of coming in contact with antimicrobial agents,
the origin and high prevalence of cfr in Staphylococcus
equorum is intriguing.
The cfr-carrying segment (including rep, Δpre/mob, cfr,
pre/mob and partial ermC) on the plasmid pHNLKJC2
from the chicken meat strain S. sciuri TLKJC2, was found
to be similar to the corresponding plasmid regions fromdifferent staphylococcal species such as the plasmid
pSS-03 (accession number JQ219851) from a bovine S.
cohnii strain and the plasmid pMSA16 (accession num-
ber JQ246438) from a bovine MRSA ST9 strain in China
(Figure 1B) [10,18]. In addition, this cfr-carrying segment
also showed high nucleotide sequence identity (98%) to
the corresponding region of plasmid pSCFS1 (accession
number AJ579365) from a bovine S. sciuri in Germany
[19]. The cfr-carrying segment (including ΔtnpA of Tn558,
IS21-558; ΔtnpB; and tnpC of Tn558, orf138, fexA) on the
plasmid pHNTLD18 from the pork strain S. equorum
TLD18 was identical to the corresponding segment of the
(A)
(B)
Figure 1 Genetic environment of cfr in plasmids pHNTLD18 and pHNLKJC2 and comparison with other similar plasmids. The arrows
indicate the positions and directions of the transcription of the genes. Regions of >98% homology are shaded in grey. Δ indicates a truncated
gene. A. genetic environment of cfr in pHNTLD18; B. genetic environment of cfr in pHNLKJC2.
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cohnii from human in China [20], the plasmid pSA737
(accession number KC206006) extracted from a human
clinical MRSA strain and the plasmid pSEPI8573 (accession
number KC222021) from a human clinical S. epidermidis
strain in the United States [21], and the plasmid pSS-02
(accession number JF834910) obtained from a porcine S.
saprophyticus strain in China(Figure 1A) [10]. These results
indicated that the horizontal transfer mediated by mobile
genetic elements such as plasmids and insertion sequences
may contribute to the spread of cfr and suggested that it is
possible to transfer cfr via mobile genetic elements from
staphylococcal isolates of animal origin to the bacterial
strains in the human body through meat consumption,
posing a serious threat to the public health.
The MICs of the cfr-positive staphylococci indicated
multiresistance phenotype in these strains other than the
PhLOPSA phenotype, suggesting limited therapeutic
options to control these cfr-carrying staphylococci.
Most of the cfr-positive staphylococcal isolates showed
low-level linezolid resistance with MIC values ranging
from 4 to 16 mg/L; this result is in agreement with pre-
viously reported linezolid MICs among cfr-carrying
staphylococci from farm animals and humans [10,11,22].
In addition, five of the cfr-positive isolates had linezolid
MIC values of 2 mg/L, which is the same as the typicallinezolid MIC90 value and not consistent with MIC value
shifts observed for isogenic cfr-negative/positive staphylo-
coccal strain pairs [23]. This finding indicated that cfr, al-
though present, is not functional or is partially silenced in
some way [24]. Although Staphylococcus strains isolated
from meat samples showed low-level of linezolid resist-
ance in the present study, emergence of the multiresis-
tance gene cfr in meat poses a potentially significant
threat to the public health, considering that the cfr-medi-
ated linezolid resistance can rapidly and widely spread
among different bacterial species.
Conclusions
To the best of our knowledge, this is the first study to
report a surprisingly high occurrence of cfr in retail meat
samples in Chinese markets. Animal meat harboring
bacteria containing the transmissible cfr would be a ser-
ious threat to the public health as these bacteria may act
as reservoirs for spreading cfr to bacteria that infect
humans, particularly in environments with a large mi-
crobial community. Recently, cfr was detected in human
isolates in China [20,25]. Thus, more attention needs to
be paid to the possibility that cfr can find its way
through the food chain to commensal or pathogenic
bacteria of humans. Considering that a limited number
of meat samples were used and that to from only one
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dissemination of cfr among staphylococcal species from
animal food sources in China is not conclusive. Thus,
continuing the surveillance of cfr gene in meat distributed
in China is critical to limit its dissemination, which could
potentially threaten the human health.Methods
Sample collection, identification of species, and cfr detection
In February 2012, 72 pork samples and 46 chicken
samples were collected from five free markets and one
supermarket in Guangzhou. The meat samples were
incubated in Luria–Bertani (LB) broth for enrichment.
Then, the cultured broth was streaked onto selective
media plates of Baird–Parker agar supplemented with
10 mg/L florfenicol. One isolate per sample was selected
for further analysis. Whole-cell DNA was prepared ac-
cording to a previously described protocol [26]. The
presence of cfr was screened by PCR with previously
described primers [5]. Species identification of the cfr-car-
rying strains was performed by the API-Staph System
(bioMérieux, France) and further confirmed by 16S rRNA
sequencing [27].Molecular typing and transformation
PFGE of all cfr-positive Staphylococcus isolates was
performed by using the CHEF Mapper System (Bio-Rad
Laboratories, Hercules, CA), according to the previously
described protocol [10]. All the plugs of genomic DNA
were digested with SmaI (TaKaRa Biotechnology, Dalian,
China). The PFGE patterns were interpreted according to
the criteria described by Tenover et al. [28]. The location
of cfr was determined by Southern blotting.
Cfr-carrying plasmids of the isolates were extracted
by using the QIAGEN Plasmid DNA Midi Kit (Qiagen,
Hilden, Germany) and then transferred into S. aureus
RN4220 by electrotransformation, as described previously
[29]. The transformants were selected on media supple-
mented with 10 mg/L florfenicol, screened for cfr by PCR
amplification, and confirmed by PFGE.Antimicrobial susceptibility testing
The MIC values of all cfr-positive original Staphylococ-
cus isolates and transformants were determined by the
broth microdilution method, according to the recom-
mendations specified in CLSI documents M100-S22
[30]. The results were interpreted according to Eucast
breakpoints (http://www.eucast.org/clinical_breakpoints/).
Isolates with an MIC of ≥16 mg/L were tentatively
considered to be florfenicol-resistant [26]. The refer-
ence strain S. aureus ATCC 29213 was used for quality
control.Cloning and sequencing of the regions flanking cfr
The regions flanking cfr in the transformant obtained
from the isolate TLKJC2 were determined by PCR
mapping. The plasmid DNA of the isolate TLD18 was
extracted and digested with EcoRI. The digested fragments
were cloned into the pUC18 vector, and the recombinant
plasmid (designated as pUC18-cfr) was introduced into
Escherichia coli DH5α with subsequent selection for the
transformant (designated as E. coli DH5α- pUC18-cfr) on
media supplemented with 10 mg/L florfenicol. The ap-
proximately 5.7-kb segment in pUC18-cfr, including cfr
and its flanking regions, was sequenced by primer walking.
The DNA sequences were compared to those deposited in
GenBank using the BLAST program (http://www.ncbi.
nlm.nih.gov/BLAST).
Nucleotide sequence accession number
The nucleotide sequences of cfr-containing fragments of
plasmids pHNLKJC2 and pHNTLD18 have been deposited
in the GenBank under the accession numbers KF751701
and KF751702, respectively.
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